Baxter Ventures

Fresenius KabiHealthcareSweden

74% match

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for critically and chronically ill patients. Its portfolio includes intravenous drugs, clinical nutrition, medical technologies, and biopharmaceuticals designed to improve patient care and treatment efficiencies worldwide.

Allmed Medical Care HoldingsHealthcare

65% match

Allmed Medical Care Holdings specializes in haemodialysis, manufacturing and distributing an end-to-end range of consumables and renal care therapies. Headquartered in the United Kingdom, the company serves healthcare providers and patients across Europe, the Middle East, and South America.

AmbuAMBUB · Health CareDenmark

64% matchPublic

Ambu A/S is a Danish medical device company that develops and manufactures single-use endoscopy, anesthesia, and patient-monitoring products. Its customers include hospitals and healthcare professionals, particularly in anesthesia, critical care, pulmonology, gastroenterology, and emergency medicine.

Fresenius GroupHealthcareGermany

64% match

Fresenius Group is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany, comprising operating companies such as Fresenius Kabi.

M/s. Renalyx Health Systems Private Limited provides end-to-end renal solutions, focusing on the early detection of chronic kidney disease (CKD) using point-of-care solutions and offering affordable and accessible dialysis treatment. The company serves patients requiring renal care and management.

Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company’s restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.